Improved Cognition in Alzheimer’s Disease With Short-Term D-Cycloserine Treatment
Data up to Jan 2025
Total Citations Per Year
Abstract
References (16)
Clinical diagnosis of Alzheimer's disease
1984 • 27,279 citations
Cerebral Blood Flow in Dementia
1975 • 3,133 citations
Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation
1983 • 3,028 citations
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
1997 • 2,394 citations
A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease
1998 • 1,575 citations
d-Cycloserine enhances implicit memory in Alzheimer patients
1996 • 150 citations
Reduced Glycine Stimulation of [3H]MK‐801 Binding in Alzheimer's Disease
1989 • 117 citations
Role of Glycine in the N‐Methyl‐d‐Aspartate‐Mediated Neuronal Cytotoxicity
1990 • 113 citations
Ante mortem cerebral amino acid concentrations indicate selective degeneration of glutamate-enriched neurons in Alzheimer's disease
1990 • 94 citations
Effects of NMDA Modulation in Scopolamine Dementiaa
1991 • 87 citations
Amino acid concentrations in cerebrospinal fluid and serum in Alzheimer's disease and vascular dementia
1993 • 66 citations
d-Cycloserine, a putative cognitive enhancer, facilitates activation of the N-methyl-d-aspartate receptor-ionophore complex in Alzheimer brain
1991 • 63 citations
D-Cycloserine Treatment of Alzheimer Disease
1994 • 53 citations
Evaluation of Cycloserine in the Treatment of Alzheimer's Disease
1995 • 49 citations
A Preliminary Study of<scp>d</scp>-Cycloserine Treatment in Alzheimer's Disease
1998 • 35 citations
Cognitive and Quantified Electroencephalographic Correlates of Cycloserine Treatment in Alzheimerʼs Disease
1995 • 28 citations